- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Erasca (NASDAQ:ERAS), Quotes and News Summary
Erasca (NASDAQ: ERAS)
Earnings
see more| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-12-20 | ||||||
| REV | |||||||
| FY 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-11-09 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Erasca Questions & Answers
You can purchase shares of Erasca (NASDAQ: ERAS) through any online brokerage.
Other companies in Erasca’s space includes: Avidity Biosciences (NASDAQ:RNA), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL), TG Therapeutics (NASDAQ:TGTX) and Sangamo Therapeutics (NASDAQ:SGMO).
The latest price target for Erasca (NASDAQ: ERAS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ERAS to fall to within 12 months (a possible -59.06% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Erasca (NASDAQ: ERAS) is $9.77 last updated August 12, 2022, 8:00 PM UTC.
The next Erasca (ERAS) dividend date is projected to be Thursday, September 1, 2022.
Erasca’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Erasca.
Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.